Journal of Substance Abuse Treatment
Volume 30, Issue 3 , Pages 191-196 , April 2006

Effect of opioid substitution therapy on alcohol metabolism

  • Nicolas C. Clark, M.B.B.S, M.P.H, FAChAM

      Affiliations

    • Turning Point Alcohol and Drug Center Inc., Victoria, Australia
    • Monash Medical Center, Victoria, Australia
    • Corresponding Author InformationCorresponding author. Turning Point Alcohol and Drug Center Inc., Fitzroy, VIC 3065, Australia. Tel.: +61 3 8413 8447; fax: +61 3 9416 3420.
    • ,
  • Paul Dietze, Ph.D

      Affiliations

    • Turning Point Alcohol and Drug Center Inc., Victoria, Australia
    • Institute for Health Services Research, Monash University, Victoria, Australia
    • ,
  • Michael G. Lenné, Ph.D

      Affiliations

    • Accident Research Center, Monash University, Victoria, Australia
    • Department of Psychology, Monash University, Victoria, Australia
    • ,
  • Jennifer R. Redman, Ph.D

      Affiliations

    • Department of Psychology, Monash University, Victoria, Australia

Received 15 April 2005 ,Revised 22 November 2005 ,Accepted 23 November 2005.

References 

  1. Adelhoj B, Petring OU, Ibsen M, Brynnum J, Poulsen HE. Buprenorphine delays drug absorption and gastric emptying in man. Acta Anaesthesiologica Scandinavica. 1985;29:599–601
  2. Anglin MD, Almog IJ, Fisher DG, Peters KR. Alcohol use by heroin addicts: Evidence for an inverse relationship. A study of methadone maintenance and drug-free treatment samples. American Journal of Drug and Alcohol. 1989;15:191–207
  3. Asnafi-Farhang S, Hatchuel P, Bourhis F, Divine C, Lagrue G. Prevalence of cannabis and tobacco use in patients attending a methadone center. Evaluation by urinary biomarkers, Annales de Medecine Interne (Paris). 2001;152(Suppl 3):IS37–IS42
  4. Borowsky SA, Lieber CS. Interaction of methadone and ethanol metabolism. Journal of Pharmacology and Experimental Therapeutics. 1978;207:123–129
  5. Chen WJ, Parnell SE, West JR. Nicotine decreases blood alcohol concentration in neonatal rats. Alcoholism Clinical and Experimental. 2001;25:1072–1077
  6. Cicero TJ, Bell RD, Wiest WG, Allison JH, Polakoski K, Robins E. Function of the male sex organs in heroin and methadone users. New England Journal of Medicine. 1975;292:882–887
  7. Cicero TJ, Bernard JD, Newman K. Effects of castration and chronic morphine administration on liver alcohol dehydrogenase and the metabolism of ethanol in the male Sprague–Dawley rat. Journal of Pharmacology and Experimental Therapeutics. 1980;215:317–324
  8. Clark N, Ritter A, Lintzeris N, Kutin J, Bammer G. Office-based LAAM maintenance for opioid dependence: A randomised comparison with methadone. Drug and Alcohol Dependence. 2001;63(Suppl 1):S28
  9. Cushman P. Alcohol and opioids: Possible interactions of clinical importance. Advances in Alcohol and Substance Abuse. 1987;6:33–46
  10. Cushman P, Kreek MJ, Gordis E. Ethanol and methadone in man: A possible drug interaction. Drug and Alcohol Dependence. 1978;3:35–42
  11. Donnelly B, Balkon J, Lasher C, Lynch V, Bidanset JH, Bianco J. Evaluation of the methadone–alcohol interaction: I. Alterations of plasma concentration kinetics. Journal of Analytical Toxicology. 1983;7:246–248
  12. Dyer KR, White J. Patterns of symptom complaints in methadone maintenance patients. Addiction. 1997;92:1445–1455
  13. Elkader A, Sproule B. Buprenorphine: Clinical pharmacokinetics in the treatment of opioid dependence. Clinical Pharmacokinetics. 2005;44:661–680
  14. Fudala PJ. LAAM—Pharmacology and pharmacokinetics, developmental history, and therapeutic considerations. Journal of Substance Abuse Treatment. 1996;17:127–132
  15. Kaiko RF, Inturrisi CE. Disposition of acetylmethadol in relation to pharmacologic action. Clinical Pharmacology and Therapeutics. 1975;18:96–103
  16. Kechagias S, Jonsson KA, Jones AW. Impact of gastric emptying on the pharmacokinetics of ethanol as influenced by cisapride. British Journal of Clinical Pharmacology. 1999;48:728–732
  17. Kreek MJ. Effects of drugs and alcohol on opiate disposition and actions. In: Factors affecting the action of narcotics. 1978;p. 717–739
  18. Kreek MJ. Metabolic interactions between opiates and alcohol. Annals of the New York Academy of Sciences. 1981;362:36–49
  19. Kreek MJ. Opioid interactions with alcohol. Advances in Alcohol and Substance Abuse. 1984;3:35–46
  20. Lenné M, Dietze P, Rumbold GR, Redman JR, Triggs TJ. The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving. Drug and Alcohol Dependence. 2003;72:271–278
  21. Lenné M, Triggs T, Redman J. Alcohol, time of day, and driving experience: Effects on simulated driving performance and subjective mood. Transportation Human Factors. 1999;1:331–346
  22. Matsumoto H, Fukui Y. Pharmacokinetics of ethanol: A review of the methodology. Addiction Biology. 2002;7:5–14
  23. Mendelson JH, Inturrisi CE, Renault P, Senay EC. Effects of acetylmethadol on plasma testosterone. Clinical Pharmacology and Therapeutics. 1976;19:371–374
  24. Oneta CM, Lieber CS, Li J, Ruttimann S, Schmid B, Lattmann J, et al. Dynamics of cytochrome P4502E1 activity in man: Induction by ethanol and disappearance during withdrawal phase. Journal of Hepatology. 2002;36:47–52
  25. Prod Info Methadone HCL. (1996). Glaxo Wellcome.
  26. Prod Info Orlaam. (2000). Roxane Laboratories.
  27. Ritter A, Lintzeris N, Clark N, Kutin J, Bammer G. A randomised trial of buprenorphine maintenance in primary care office-based settings: Clinical guidelines, training programs and efficacy. Drug and Alcohol Dependence. 2001;63(Suppl 1):S131
  28. Ritter AJ, Lintzeris N, Clark N, Kutin JJ, Bammer G, Panjari M. A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia. Addiction. 2003;98:1605–1613
  29. Shinderman M, Maxwell S, Brawand-Amey M, Golay KP, Baumann P, Eap CB. Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses. Drug and Alcohol Dependence. 2003;69:205–211
  30. Tommasello AC, Adir J. Alcohol and the steady-state disposition kinetics of methadone in rats. Journal of Studies on Alcohol. 1984;45:155–159
  31. Trotter TN, Rowbotham DJ, Windram I, Mushambi MC. Effect of sublingual buprenorphine on gastric emptying of a liquid meal. British Journal of Anaesthesia. 1991;67:748–750
  32. Umans HR, Kreek MJ, Rodriguez R, Raghunath J. Effects of chronic methadone treatment on the rate of ethanol elimination in the female rat in vivo. American Gastroenterology Association/American Association for the Study of Liver Diseases Meeting. Gastroenterology. 1982;82:1247
  33. Wang JS, DeVane CL. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. Drug Metabolism and Disposition. 2003;31:742–747
  34. Wendell GD, Thurman RG. Effect of ethanol concentration on rates of ethanol elimination in normal rats in vivo. Currents in Alcoholism. 1979;5:81–89
  35. Whitehouse LW, Templeton D, Paul CJ. Ethanol inhibition of hepatic uptake of dl-[2-14C]methadone in the rat and its consequence. Journal of Studies on Alcohol. 1979;40:7–18

PII: S0740-5472(05)00250-3

doi: 10.1016/j.jsat.2005.11.010

Journal of Substance Abuse Treatment
Volume 30, Issue 3 , Pages 191-196 , April 2006

Article Tools

* Image Usage & Resolution